ARF influences diabetes through promoting the proliferation and malignant development of β cells

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Fedewa SA, Goding SA, et al. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66:31–42.
   PubMed Web of Science ®Google Scholar
• Linos E, Spanos D, Rosner BA, et al. Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. J Natl Cancer Inst. 2008;100:1352–1360.
   PubMedGoogle Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. Ca Cancer J Clin. 2016;66:115–132.
   PubMed Web of Science ®Google Scholar
• Rehman K, Akash MSH. Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: how are they interlinked? J Cell Biochem. 2017;118:3577–3585.
   PubMed Web of Science ®Google Scholar
• Sakuraba H, Mizukami H, Yagihashi N, et al. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia. 2002;45:85–96.
   PubMed Web of Science ®Google Scholar
• Akash MSH, Rehman K, Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2013;114:525–531.
   PubMed Web of Science ®Google Scholar
• Sanchez-Cespedes M, Reed AL, Buta M, et al. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in Non-small cell lung cancer. Oncogene. 1999;18:5843–5849.
   PubMed Web of Science ®Google Scholar
• Nicholson SA, Okby NT, Khan MA, et al. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. Cancer Res. 2001;61:5636–5643.
   PubMed Web of Science ®Google Scholar
• Gao N, Hu YD, Cao XY, et al. The exogenous wild-type p14ARF gene induces growth arrest and promotes radio sensitivity in human lung cancer cell lines. J Cancer Res Clin Oncol. 2001;127:359–367.
   PubMed Web of Science ®Google Scholar
• Kamijo T, Bodner S, van de Kamp E, et al. Tumor spectrum in ARF-deficient mice. Cancer Res. 1999;59:2217–2222.
   PubMed Web of Science ®Google Scholar
• Busch SE, Gurley KE, Moser RD, et al. ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model. J Pathol. 2012;227:298–305.
   PubMed Web of Science ®Google Scholar
• Rogers S. Age of the host and other factors affecting the production with urethane of pulmonary adenomas in mice. J Exp Med. 1951;93:427–449.
   PubMed Web of Science ®Google Scholar
• Barilla ML, Carsons SE. Fibronectin fragments and their role in inflammatory arthritis. Semin Arthritis Rheum. 2000;29:252–265.
   PubMed Web of Science ®Google Scholar
• Riddle MC. Oral pharmacologic management of type 2 diabetes. Am Fam Physician. 1999;60:2613–2620.
   PubMed Web of Science ®Google Scholar
• Skyler JS. Diabetes mellitus: pathogenesis and treatment strategies. J Med Chem. 2004;47:4113–4117.
   PubMed Web of Science ®Google Scholar
• D’Amico M, Wu K, Fu M, et al. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements. Cancer Res. 2004;64:4122–4130.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Z, Kastens E, et al. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice. Cancer Res. 2003;63:4389–4395.
   PubMed Web of Science ®Google Scholar
• Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230–238.
   PubMed Web of Science ®Google Scholar
• Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54:2060–2069.
   PubMed Web of Science ®Google Scholar
• Truong W, Lakey JR, Ryan EA, et al. Clinical islet transplantation at the University of Alberta the Edmonton experience. ClinTranspl. 2005;0:153–172.
   Google Scholar
• Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355:1318–1330.
   PubMed Web of Science ®Google Scholar
• Molano RD, Pileggi A, Berney T, et al. Long-term islet allograft survival in no obese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. Transplantation. 2003;75:1812–1819.
   PubMed Web of Science ®Google Scholar